Origen Therapeutics
closedOrigen Therapeutics develops therapeutic products from avian transgenic animal technology.
Launch date
Employees
Market cap
-
Enterprise valuation
$15—22m (Dealroom.co estimates Aug 2010.)
Burlingame California (HQ)
Authorizing premium user...